12.04.24 -- Research Explores Alternative To EU-Banned Triton X-100

Learn how transferring a batch chromatography process into a multi-column format and scaling that process up to continuous perfusion dramatically reduced protein A resin requirements.

Explore results from a study demonstrating the capability of an intensified, single-use downstream process for a fed-batch cell culture harvest producing a representative mAb at an industrial scale.

Choosing between turbulent and microfluidic mixing methods in your lipid nanoparticle (LNP) production can have a significant impact when scaling up production.

Pouring millions into the infrastructure and quality systems necessary to move away from manual filling is unrealistic and detracts from your strengths in drug development.

Advancements in purification, delivery mechanisms, and stability during storage and transport will enable the future of mRNA-based therapies.

Discover how Praesto Jetted A50 HipH resin offers superior viral clearance at mild pH conditions, minimizing protein aggregation and improving yield during monoclonal antibody purification.

Streamline your AAV gene therapy production process with custom buffers. Learn how optimized formulations can enhance purity, scalability, and regulatory compliance.

Modern solutions are continuing to be developed to help those working in biologics overcome historic Exosomes / Extracellular Vesicles challenges.

See how our expertise in formulation and process development can ensure a seamless scale-up from laboratory to full-scale production of lyophilized injectable products.

Orphan drug development is a journey marked by challenges at every step. From patient recruitment to aseptic fill finish, overcoming hurdles is critical for bringing life-saving treatments to market.

Uncover how a fully disposable upstream and downstream platform process in antibody production can increase production timelines, enhance scalability, and reduce risk in biologics manufacturing.

Here, speakers describe when filter validation should be performed, what is required from an end user and laboratory testing perspective, and how to achieve first-time success for various drug products.

Consider some of the more challenging aspects surrounding in-use testing for parenteral delivery along with potential strategies to address these issues.

This flexible freeze container maintains package integrity after freezing at -86 °C. (-123 °F) through its durable design, minimizing product loss due to package failure.